(Q40058870)

17 September 2017

title

HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration (English)

1 reference

17 September 2017

1 reference

1 reference

Rosaria Bassi

1

1 reference

17 September 2017

Paola Giussani

2

1 reference

17 September 2017

Viviana Anelli

3

1 reference

17 September 2017

Thomas Colleoni

4

1 reference

17 September 2017

Marco Pedrazzi

5

1 reference

17 September 2017

Mauro Patrone

6

1 reference

17 September 2017

Paola Viani

7

1 reference

17 September 2017

Bianca Sparatore

8

1 reference

17 September 2017

Edon Melloni

9

1 reference

17 September 2017

Laura Riboni

10

1 reference

17 September 2017

language of work or name

1 reference

2 November 2007

1 reference

Journal of Neuro-Oncology

17 September 2017

published in

1 reference

17 September 2017

volume

87

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

23-33

1 reference

The WHO classification of tumors of the nervous system

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9488-Y

Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9488-Y

21 January 2018

Chromatin and cell death

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9488-Y

Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9488-Y

Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellular tumour spheroid model

21 January 2018

1 reference

12 December 2020

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

12 December 2020

Biological mechanisms of glioma invasion and potential therapeutic targets

1 reference

12 December 2020

The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site

1 reference

12 December 2020

Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death

1 reference

12 December 2020

Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis

1 reference

12 December 2020

Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator

1 reference

12 December 2020

Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli.

1 reference

12 December 2020

Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation.

1 reference

12 December 2020

Progress towards therapeutic small molecule MEK inhibitors for use in cancer therapy

1 reference

12 December 2020

Extracellular role of HMGB1 in inflammation and sepsis.

1 reference

12 December 2020

Basic fibroblast growth factor-induced proliferation of primary astrocytes. evidence for the involvement of sphingomyelin biosynthesis

1 reference

12 December 2020

Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.

1 reference

12 December 2020

Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.

1 reference

12 December 2020

HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay

1 reference

12 December 2020

Masquerader: high mobility group box-1 and cancer

1 reference

12 December 2020

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

1 reference

12 December 2020

Molecular pathways triggering glioma cell invasion

1 reference

12 December 2020

Regulation of cell migration by amphoterin.

1 reference

12 December 2020

New advances on structural and biological functions of ceramide in apoptotic/necrotic cell death and cancer

1 reference

12 December 2020

Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion

1 reference

12 December 2020

HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma

1 reference

12 December 2020

Biologically active sphingolipids in cancer pathogenesis and treatment

1 reference

12 December 2020

Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis

1 reference

12 December 2020

Dichotomy of astrocytoma migration and proliferation.

1 reference

12 December 2020

High-mobility group box 1 (HMGB1) protein: friend and foe.

1 reference

12 December 2020

Molecular mechanisms in gliomagenesis

1 reference

12 December 2020

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

12 December 2020

An essential role for Rac in Ras transformation

1 reference

12 December 2020

The cytokine activity of HMGB1.

1 reference

12 December 2020

Molecular changes in gliomas

1 reference

12 December 2020

HMGB1: a signal of necrosis

1 reference

12 December 2020

Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma

1 reference

12 December 2020

The ERK cascade: a prototype of MAPK signaling

1 reference

12 December 2020

Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer

1 reference

12 December 2020

The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in viv

1 reference

12 December 2020

Understanding RAGE, the receptor for advanced glycation end products

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

1 reference

12 December 2020

Dealing with death: HMGB1 as a novel target for cancer therapy

1 reference

12 December 2020

Role of synaptojanin 2 in glioma cell migration and invasion

1 reference

12 December 2020

Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function

1 reference

12 December 2020

Akt protein kinase inhibits non-apoptotic programmed cell death induced by ceramide

1 reference

12 December 2020

Amphoterin as an extracellular regulator of cell motility: from discovery to disease.

1 reference

12 December 2020

Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus

1 reference

12 December 2020

10.1007/S11060-007-9488-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

1042521244

0 references

1 reference